使用IETA-1多项回归模型评估无异常子宫出血女性子宫内膜恶性及其他宫腔内病变风险:验证研究
本研究为回顾性验证研究,在IETA-3前瞻性观察多中心队列(n=1745)中验证IETA-1模型。该模型对子宫内膜癌或子宫内膜上皮内瘤变的AUC为0.81,观察/期望比为0.51,能较好区分良性及恶性病变但高估恶性风险,对四种组织学结局分类的PDI为0.68。
要点
- IETA-1模型在无异常子宫出血女性中区分恶性与良性子宫内膜的AUC为0.81。
- 模型对子宫内膜癌或EIN的观察/期望比为0.51,提示高估恶性风险。
- 模型区分四种组织学结局的PDI为0.68,区分萎缩与其他宫腔病变的AUC为0.96。
核心结论
- IETA-1模型在无异常出血患者中能较好区分宫腔良恶性病变,但高估恶性风险;对四种组织学结局分类也有较好区分能力。
研究设计与样本
- 回顾性验证研究,在IETA-3前瞻性观察多中心研究队列(n=1745)中验证IETA-1模型。
- IETA-3研究纳入2011年1月至2018年12月期间在七个超声中心之一接受标准化经阴道超声检查的无阴道出血女性。
主要发现
- IETA-3队列中位年龄51岁(范围20-85),51%(887/1745)为绝经后女性。
- 组织学显示子宫内膜癌或EIN 29例(2%),子宫内膜息肉或宫腔内肌瘤1094例(63%),增殖期或分泌期子宫内膜、子宫内膜炎或无 atypia 增生144例(8%),子宫内膜萎缩265例(15%)。
- IETA-1模型区分恶性(子宫内膜癌或EIN)与良性子宫内膜的AUC为0.81(95%CI 0.73-0.89,n=1745),子宫内膜癌或EIN的观察/期望比为0.51(95%CI 0.32-0.82)。
- 模型对四种组织学结局分类的PDI为0.68(95%CI 0.62-0.73,n=1532),区分子宫内膜萎缩与其他宫腔病变的AUC为0.96(95%CI 0.95-0.98)。
- 在子宫内膜可测量患者中(n=1689),模型AUC为0.83(95%CI 0.75-0.91),单独使用子宫内膜厚度预测恶性的AUC为0.62(95%CI 0.52-0.73),AUC差值0.21(95%CI 0.08-0.32)。
临床怎么用
- 作者未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the ability of the International Endometrial Tumor Analysis (IETA)-1 polynomial regression model to estimate the risk of endometrial cancer (EC) and other intracavitary uterine pathology in women without abnormal uterine bleeding. METHODS: This was a retrospective study, in which we validated the IETA-1 model on the IETA-3 study cohort (n = 1745). The IETA-3 study is a prospective observational multicenter study. It includes women without vaginal bleeding who underwent a standardized transvaginal ultrasound examination in one of seven ultrasound centers between January 2011 and December 2018. The ultrasonography was performed either as part of a routine gynecological examination, during follow-up of non-endometrial pathology, in the work-up before fertility treatment or before treatment for uterine prolapse or ovarian pathology. Ultrasonographic findings were described using IETA terminology and were compared with histology, or with results of clinical and ultrasound follow-up of at least 1 year if endometrial sampling was not performed. The IETA-1 model, which was created using data from patients with abnormal uterine bleeding, predicts four histological outcomes: (1) EC or endometrial intraepithelial neoplasia (EIN); (2) endometrial polyp or intracavitary myoma; (3) proliferative or secretory endometrium, endometritis, or endometrial hyperplasia without atypia; and (4) endometrial atrophy. The predictors in the model are age, body mass index and seven ultrasound variables (visibility of the endometrium, endometrial thickness, color score, cysts in the endometrium, non-uniform echogenicity of the endometrium, presence of a bright edge, presence of a single dominant vessel). We analyzed the discriminative ability of the model (area under the receiver-operating-characteristics curve (AUC); polytomous discrimination index (PDI)) and evaluated calibration of its risk estimates (observed/expected ratio). RESULTS: The median age of the women in the IETA-3 cohort was 51 (range, 20-85) years and 51% (887/1745) of the women were postmenopausal. Histology showed EC or EIN in 29 (2%) women, endometrial polyps or intracavitary myomas in 1094 (63%), proliferative or secretory endometrium, endometritis, or hyperplasia without atypia in 144 (8%) and endometrial atrophy in 265 (15%) women. The endometrial sample had insufficient material in five (0.3%) cases. In 208 (12%) women who did not undergo endometrial sampling but were followed up for at least 1 year without clinical or ultrasound signs of endometrial malignancy, the outcome was classified as benign. The IETA-1 model had an AUC of 0.81 (95% CI, 0.73-0.89, n = 1745) for discrimination between malignant (EC or EIN) and benign endometrium, and the observed/expected ratio for EC or EIN was 0.51 (95% CI, 0.32-0.82). The model was able to categorize the four histological outcomes with considerable accuracy: the PDI of the model was 0.68 (95% CI, 0.62-0.73) (n = 1532). The IETA-1 model discriminated very well between endometrial atrophy and all other intracavitary uterine conditions, with an AUC of 0.96 (95% CI, 0.95-0.98). Including only patients in whom the endometrium was measurable (n = 1689), the model's AUC was 0.83 (95% CI, 0.75-0.91), compared with 0.62 (95% CI, 0.52-0.73) when using endometrial thickness alone to predict malignancy (difference in AUC, 0.21; 95% CI, 0.08-0.32). In postmenopausal women with measurable endometrial thickness (n = 848), the IETA-1 model gave an AUC of 0.81 (95% CI, 0.71-0.91), while endometrial thickness alone gave an AUC of 0.70 (95% CI, 0.60-0.81) (difference in AUC, 0.11; 95% CI, 0.01-0.20). CONCLUSION: The IETA-1 model discriminates well between benign and malignant conditions in the uterine cavity in patients without abnormal bleeding, but it overestimates the risk of malignancy. It also discriminates well between the four histological outcome categories. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Heremans R, Wynants L, Valentin L, et al. Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA-1 multinomial regression model: validation study. Ultrasound Obstet Gynecol. 2024. PMID: 37927006. doi:10.1002/uog.27530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。